menu search

phathom pharmaceuticals to participate in upcoming investor conferences

FLORHAM PARK, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) -- phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a b...

October 25, 2023, 8:01 am

Following up on phathom pharmaceuticals

phathom Pharmaceuticals is a small biopharma firm focused on developing treatments for gastrointestinal...

October 5, 2023, 12:43 pm

Shareholder alert: levi & korsinsky, llp notifies shareholders of an investigation concerning possible breaches of fiduciary duty by certain officers and directors of phathom pharmaceuticals, inc. (na

NEW YORK, Aug. 22, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky announces that it has commenced an investigation of Phantom Pharmaceuticals, Inc. (NASDA...

August 22, 2023, 10:03 pm

phathom pharma: time to take profits (rating downgrade)

phathom Pharmaceuticals, Inc. is trading near 52-week highs. Despite its potential, there are reasons, ...

July 14, 2023, 4:12 pm

3 top breakout stocks worth a buy for attractive returns

phathom Pharmaceuticals (PHAT), Universal Stainless & Alloy Products (USAP) and Arlo Technologies (ARLO...

July 7, 2023, 10:08 am

Bragar eagel & squire, p.c. is investigating integra, chinook, phathom, and akumin and encourages investors to contact the firm

NEW YORK, June 19, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...

June 20, 2023, 1:00 am

Bragar eagel & squire, p.c. is investigating phathom, reata, and comerica and encourages investors to contact the firm

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...

June 5, 2023, 1:00 am

Does phathom pharmaceuticals, inc. (phat) have the potential to rally 81.38% as wall street analysts expect?

The mean of analysts' price targets for phathom Pharmaceuticals, Inc. (PHAT) points to an 81.4% upside ...

June 1, 2023, 11:05 am

phathom pharmaceuticals, inc. (phat) may find a bottom soon, here's why you should buy the stock now

phathom Pharmaceuticals, Inc. (PHAT) appears to have found support after losing some value lately, as i...

May 26, 2023, 11:05 am

Phat investor alert: levi & korsinsky, llp reminds investors of an investigation involving possible securities fraud violations by officers of phathom pharmaceuticals, inc.

NEW YORK, May 26, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky notifies investors that it has commenced an investigation of ...

May 26, 2023, 9:20 am

phathom pharmaceuticals announces pricing of public offering of common stock

FLORHAM PARK, N.J., May 23, 2023 (GLOBE NEWSWIRE) — phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a b...

May 23, 2023, 11:41 pm

Phat investor alert: rosen, a top ranked law firm, encourages phathom pharmaceuticals, inc. investors to inquire about securities class action investigation – phat

NEW YORK, May 19, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities clai...

May 20, 2023, 1:50 am

phathom pharmaceuticals presents new data at digestive disease week® (ddw) 2023

Higher H. pylori eradication rates demonstrated with vonoprazan-based regimens vs. lansoprazole triple therapy, regardless of different baseline demog...

May 9, 2023, 12:00 pm

phathom pharmaceuticals, inc: company investigated by the portnoy law firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 14, 2023 (GLOBE NEWSWIRE) — The Portnoy...

April 14, 2023, 10:37 pm

Here's why phathom pharmaceuticals, inc. (phat) is a great 'buy the bottom' stock now

phathom Pharmaceuticals, Inc. (PHAT) appears to have found support after losing some value lately, as i...

March 27, 2023, 11:26 am

Rosen, a global and leading law firm, encourages phathom pharmaceuticals, inc. investors to inquire about securities class action investigation – phat

NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securit...

March 10, 2023, 2:51 am

All you need to know about phathom pharmaceuticals, inc. (phat) rating upgrade to buy

phathom Pharmaceuticals, Inc. (PHAT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing opt...

March 7, 2023, 1:32 pm

Rosen, national trial lawyers, encourages phathom pharmaceuticals, inc. investors to inquire about securities class action investigation – phat

NEW YORK, Feb. 28, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securiti...

March 1, 2023, 12:38 am

phathom's stock falls after receiving fda letters

Shares of phathom Pharmaceuticals Inc. PHAT, -0.60% tumbled about 23% in premarket trading on Friday, t...

February 10, 2023, 7:59 am

Bragar eagel & squire, p.c. is investigating credit acceptance, and phathom and encourages investors to contact the firm

NEW YORK, Feb. 03, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...

February 4, 2023, 2:00 am


Search within

Pages Search Results: